Literature DB >> 9508308

Molecular analysis of non-O1, non-O139 Vibrio cholerae associated with an unusual upsurge in the incidence of cholera-like disease in Calcutta, India.

C Sharma1, M Thungapathra, A Ghosh, A K Mukhopadhyay, A Basu, R Mitra, I Basu, S K Bhattacharya, T Shimada, T Ramamurthy, T Takeda, S Yamasaki, Y Takeda, G B Nair.   

Abstract

There was an inexplicable upsurge in the incidence of non-O1, non-O139 Vibrio cholerae among hospitalized patients admitted to the Infectious Diseases Hospital, Calcutta, India, between February and March 1996. Of the 18 strains of V. cholerae isolated during this period, 15 belonged to the non-O1, non-O139 serogroups (4 belonged to O144, 3 belonged to O11, 1 each belonged to O6, O8, O12, O19, O39, and O58, and 2 strains could not be typed), 2 belonged to the O139 serogroup, and 1 belonged to the O1 serogroup. Cell-free culture supernatants of 13 representative non-O1, non-O139 V. cholerae strains evoked a distinct cytotoxic effect on CHO and HeLa cells, and the strains examined produced the nonmembrane-damaging cytotoxin. By several PCR assays, it was determined that none of the non-O1, non-O139 strains were positive for the ctxA, zot, ace, and tcpA genes and for the genes representing the heat-labile toxin, heat-stable toxin, and verotoxin of Escherichia coli and the various variants of these genes. Studies on the clonality of non-O1, non-O139 V. cholerae strains by restriction fragment length polymorphism (RFLP) analysis of rRNA genes and of other genes (hlyA, hlyU, hlx, toxR, and attRS1) and by pulsed-field gel electrophoresis (PFGE) collectively indicate that the upsurge which occurred in February and March 1996 was caused by strains belonging to different clones. Overall, there was an excellent correlation between the results of ribotyping, RFLP analysis of various genes, and PFGE, with strains belonging to a particular serogroup showing nearly identical restriction patterns and PFGE profiles. It is clear from this study that some serogroups of V. cholerae can cause diarrhea by a mechanism quite different from that of toxigenic V. cholerae O1 and O139, and we have proposed the nomenclature of enteropathogenic V. cholerae to include these serogroups.

Entities:  

Mesh:

Year:  1998        PMID: 9508308      PMCID: PMC104621          DOI: 10.1128/JCM.36.3.756-763.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Amino-terminal domain of the El Tor haemolysin of Vibrio cholerae O1 is expressed in classical strains and is cytotoxic.

Authors:  R A Alm; G Mayrhofer; I Kotlarski; P A Manning
Journal:  Vaccine       Date:  1991-08       Impact factor: 3.641

2.  Production of monoclonal antibodies to the non-membrane-damaging cytotoxin (NMDCY) purified from Vibrio cholerae O26 and distribution of NMDCY among strains of Vibrio cholerae and other enteric bacteria determined by monoclonal-polyclonal sandwich enzyme-linked immunosorbent assay.

Authors:  P K Saha; G B Nair
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

3.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

4.  Enterotoxicity of El Tor-like hemolysin of non-O1 Vibrio cholerae.

Authors:  Y Ichinose; K Yamamoto; N Nakasone; M J Tanabe; T Takeda; T Miwatani; M Iwanaga
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

5.  Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India.

Authors:  T Ramamurthy; S Garg; R Sharma; S K Bhattacharya; G B Nair; T Shimada; T Takeda; T Karasawa; H Kurazano; A Pal
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

6.  Construction and fine mapping of recombinant plasmids containing the rrnB ribosomal RNA operon of E. coli.

Authors:  J Brosius; A Ullrich; M A Raker; A Gray; T J Dull; R R Gutell; H F Noller
Journal:  Plasmid       Date:  1981-07       Impact factor: 3.466

7.  Detection of heat-stable enterotoxin in a cholera toxin gene-positive strain of Vibrio cholerae O1.

Authors:  T Takeda; Y Peina; A Ogawa; S Dohi; H Abe; G B Nair; S C Pal
Journal:  FEMS Microbiol Lett       Date:  1991-05-01       Impact factor: 2.742

8.  Evaluation of the multitest medium for rapid presumptive identification of Vibrio cholerae from environmental sources.

Authors:  G B Nair; S Misra; R K Bhadra; S C Pal
Journal:  Appl Environ Microbiol       Date:  1987-05       Impact factor: 4.792

9.  Non-01 Vibrio cholerae infections in Cancun, Mexico.

Authors:  M J Finch; J L Valdespino; J G Wells; G Perez-Perez; F Arjona; A Sepulveda; D Bessudo; P A Blake
Journal:  Am J Trop Med Hyg       Date:  1987-03       Impact factor: 2.345

10.  New medium for the production of cholera toxin by Vibrio cholerae O1 biotype El Tor.

Authors:  M Iwanaga; K Yamamoto
Journal:  J Clin Microbiol       Date:  1985-09       Impact factor: 5.948

View more
  50 in total

1.  Cloning and sequencing of the genes downstream of the wbf gene cluster of Vibrio cholerae serogroup O139 and analysis of the junction genes in other serogroups.

Authors:  S Sozhamannan; Y K Deng; M Li; A Sulakvelidze; J B Kaper; J A Johnson; G B Nair; J G Morris
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

2.  Phenotypic and genotypic characterization Vibrio cholerae O139 of clinical and aquatic isolates in China.

Authors:  Bai-sheng Li; Hai-ling Tan; Duo-chun Wang; Xiao-ling Deng; Jing-diao Chen; Hao-jie Zhong; Bi-xia Ke; Chang-wen Ke; Biao Kan
Journal:  Curr Microbiol       Date:  2010-11-16       Impact factor: 2.188

3.  Virulence profile and clonal relationship among the Vibrio cholerae isolates from ground and surface water in a cholera endemic area during rainy season.

Authors:  A K Goel; M Jain; P Kumar; D V Kamboj; L Singh
Journal:  Folia Microbiol (Praha)       Date:  2010-03-25       Impact factor: 2.099

4.  Detection of Vibrio cholerae by real-time nucleic acid sequence-based amplification.

Authors:  Else M Fykse; Gunnar Skogan; William Davies; Jaran Strand Olsen; Janet M Blatny
Journal:  Appl Environ Microbiol       Date:  2007-01-12       Impact factor: 4.792

5.  RTX toxin actin cross-linking activity in clinical and environmental isolates of Vibrio cholerae.

Authors:  Christina L Cordero; Shanmuga Sozhamannan; Karla J Fullner Satchell
Journal:  J Clin Microbiol       Date:  2007-05-23       Impact factor: 5.948

6.  Cholera in Vietnam: changes in genotypes and emergence of class I integrons containing aminoglycoside resistance gene cassettes in vibrio cholerae O1 strains isolated from 1979 to 1996.

Authors:  A Dalsgaard; A Forslund; N V Tam; D X Vinh; P D Cam
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Predictability of Vibrio cholerae in Chesapeake Bay.

Authors:  Valérie R Louis; Estelle Russek-Cohen; Nipa Choopun; Irma N G Rivera; Brian Gangle; Sunny C Jiang; Andrea Rubin; Jonathan A Patz; Anwar Huq; Rita R Colwell
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

8.  Analysis of clinical and environmental strains of nontoxigenic Vibrio cholerae for susceptibility to CTXPhi: molecular basis for origination of new strains with epidemic potential.

Authors:  S M Faruque; M N Saha; A R Alim; M J Albert; K M Islam; J J Mekalanos
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Molecular analyses of Vibrio cholerae O1 clinical strains, including new nontoxigenic variants isolated in Mexico during the Cholera epidemic years between 1991 and 2000.

Authors:  Marcial Leonardo Lizárraga-Partida; Marie-Laure Quilici
Journal:  J Clin Microbiol       Date:  2009-02-11       Impact factor: 5.948

10.  Molecular typing of Vibrio cholerae O1 isolates from Thailand by pulsed-field gel electrophoresis.

Authors:  Pramuan Tapchaisri; Mathukorn Na-Ubol; Watcharee Tiyasuttipan; Sansanee C Chaiyaroj; Shinji Yamasaki; Thitima Wongsaroj; Hideo Hayashi; G Balakrish Nair; Manas Chongsa-Nguan; Hisao Kurazono; Wanpen Chaicumpa
Journal:  J Health Popul Nutr       Date:  2008-03       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.